The ability to screen for multiple diseases simultaneously will enable better disease surveillance. In particular, the occurrence of rare but potentially devastating diseases could be continuously monitored along with more common endemic diseases. Early identification of these exotic diseases will allow for rapid containment and could prevent catastrophic losses in the event of an outbreak.
Lightweight, disposable Palladium™ test cartridges automate the processes of a fully equipped lab in record time.
INT is looking at future development of tests for:
Stay up to date on the latest news, technology and developments by subscribing to the newsletter.
Integrated Nano-Technologies, Inc. is committed to providing fast, accurate test results that improve biological identification for a variety of applications. Founded in 2000 by an interdisciplinary team of scientists and engineers, INT has developed a robust, on-site diagnostic platform replacing traditionally time-intensive and complex lab processes.